关注
Seok Jin Kim
Seok Jin Kim
Samsung Medical Center, Sungkyunkwan University School of Medicine
在 skku.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase
YL Kwong, TSY Chan, D Tan, SJ Kim, LM Poon, B Mow, PL Khong, ...
Blood, The Journal of the American Society of Hematology 129 (17), 2437-2442, 2017
4972017
SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group
YL Kwong, WS Kim, ST Lim, SJ Kim, T Tang, E Tse, AYH Leung, CS Chim
Blood, The Journal of the American Society of Hematology 120 (15), 2973-2980, 2012
4502012
Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium …
SJ Kim, K Kim, BS Kim, CY Kim, C Suh, J Huh, SW Lee, JS Kim, J Cho, ...
Journal of clinical oncology 27 (35), 6027-6032, 2009
4002009
A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma
HY Yoo, MK Sung, SH Lee, S Kim, H Lee, S Park, SC Kim, B Lee, K Rho, ...
Nature genetics 46 (4), 371-375, 2014
3952014
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis
SJ Kim, DH Yoon, A Jaccard, WJ Chng, ST Lim, H Hong, Y Park, ...
The lancet oncology 17 (3), 389-400, 2016
3572016
Expression of HIF-1α, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer
SJ Kim, ZN Rabbani, MW Dewhirst, Z Vujaskovic, RT Vollmer, ...
Lung cancer 49 (3), 325-335, 2005
2502005
Multicenter phase II study of bendamustine plus rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma
K Ohmachi, N Niitsu, T Uchida, SJ Kim, K Ando, N Takahashi, ...
Journal of clinical oncology 31 (17), 2103-2109, 2013
2052013
Cilta-cel or standard care in lenalidomide-refractory multiple myeloma
J San-Miguel, B Dhakal, K Yong, A Spencer, S Anguille, MV Mateos, ...
New England Journal of Medicine 389 (4), 335-347, 2023
1892023
Type II enteropathy‐associated T‐cell lymphoma: a multicenter analysis from the Asia Lymphoma Study Group
E Tse, H Gill, F Loong, SJ Kim, SB Ng, T Tang, YH Ko, WJ Chng, ST Lim, ...
American journal of hematology 87 (7), 663-668, 2012
1732012
Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type
S Lee, HY Park, SY Kang, SJ Kim, J Hwang, S Lee, SH Kwak, KS Park, ...
Oncotarget 6 (19), 17764, 2015
1602015
Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study Group
SJ Kim, C Hsu, YQ Song, K Tay, XN Hong, J Cao, JS Kim, HS Eom, ...
European journal of cancer 49 (16), 3486-3496, 2013
1502013
Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone
SJ Kim, HJ Kang, JS Kim, SY Oh, CW Choi, SI Lee, JH Won, MK Kim, ...
Blood, The Journal of the American Society of Hematology 117 (6), 1958-1965, 2011
1482011
Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL)
SJ Kim, CW Choi, YC Mun, SY Oh, HJ Kang, SI Lee, JH Won, MK Kim, ...
BMC cancer 11, 1-12, 2011
1452011
Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type
SJ Kim, BS Kim, CW Choi, J Choi, I Kim, YH Lee, JS Kim
Annals of oncology 18 (8), 1382-1387, 2007
1442007
Bortezomib in combination with CHOP as first-line treatment for patients with stage III/IV peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 trial
SJ Kim, DH Yoon, HJ Kang, JS Kim, SK Park, HJ Kim, J Lee, BY Ryoo, ...
European journal of cancer 48 (17), 3223-3231, 2012
1362012
Concurrent chemoradiotherapy followed by l-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II …
SJ Kim, DH Yang, JS Kim, JY Kwak, HS Eom, DS Hong, JH Won, JH Lee, ...
Annals of hematology 93, 1895-1901, 2014
1302014
Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)
YR Kim, JS Kim, YH Min, DH Yoon, HJ Shin, YC Mun, Y Park, YR Do, ...
Journal of Hematology & Oncology 5, 1-9, 2012
1182012
Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project
CP Fox, M Civallero, YH Ko, M Manni, T Skrypets, S Pileri, SJ Kim, ...
The Lancet Haematology 7 (4), e284-e294, 2020
1172020
Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study
SJ Kim, JW Lee, CW Jung, CK Min, B Cho, HJ Shin, JS Chung, H Kim, ...
haematologica 95 (11), 1935, 2010
1162010
Carbonic Anhydrase IX in Early-Stage Non–Small Cell Lung Cancer
SJ Kim, ZN Rabbani, RT Vollmer, EG Schreiber, E Oosterwijk, ...
Clinical cancer research 10 (23), 7925-7933, 2004
1152004
系统目前无法执行此操作,请稍后再试。
文章 1–20